Amphastar Pharmaceuticals(AMPH) - 2024 Q3 - Quarterly Results

EXHIBIT 99.1 Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024 Reports Net Revenues of $191.2 Million for the Three Months Ended September 30, 2024 RANCHO CUCAMONGA, CA – November 6, 2024 – Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) ("Amphastar" or the "Company") today reported results for the three months ended September 30, 2024. Third quarter Highlights ● Net revenues of $191.2 million for the third quarter ● GAAP net income of $40.4 million, or $0.78 p ...